DUAL-ENERGY CONTRAST-ENHANCED DIGITAL SUBSTRACTION M

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$99,996.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA107758-01
Award Id:
70509
Agency Tracking Number:
CA107758
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
SCIENCE RESEARCH LABORATORY, 15 WARD ST, SOMERVILLE, MA, 02143
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
ALLEN FLUSBERG
(617) 547-1122
AFLUSBERG@SRL.COM
Business Contact:
JONAH JACOB
(617) 547-1122
JJACOB@SRL.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Early detection of breast cancer is critical to patient outcome. The specific aim of this program is to demonstrate dual-energy contrast-enhanced digital subtraction mammography (DE-CEDSM) using a proprietary quasi-monochromatic x-ray source (QMS) technology currently under development at SRL. Using a broadband source, DE-CEDSM has already been demonstrated to enhance breast tumors that are otherwise mammographically occult. A promising clinical demonstration of DE-CEDSM has been recently performed by our collaborator Dr. John Lewin of the University of Colorado Health Sciences Center. The use of optimized quasi-monochromatic radiation will significantly improve the sensitivity such that DE-CEDSM will be able to detect smaller tumors that would otherwise be masked by tissue and fat variations in the breast. SRL's QMS technology is currently under development for improving angiographic images. In this Phase I project, we will quantify the improvements in image quality and reduction of dose that can be achieved by using a QMS for mammography as compared to using a broadband source as has been demonstrated by Dr. Lewin. Preliminary calculations show that the improvements should be significant with the radiation dose requirement dropping by half and suppression of tissue features, a critical feature of the technique, improving as well. Following a successful Phase I program, the Phase II effort will concentrate on building and testing a prototype that integrates a QMS with a full-field digital mammography system. This technology will allow for successive real-time subtracted contrast-enhanced mammograms using industry standard iodinated contrast agents. Contrast agent can be administered prior to breast compression, allowing for adequate perfusion of breast tissue. The dual-energy method will allow for viewing suspected lesions from multiple angles as well as for measuring contrast uptake and dispersion over time. Measurements of contrast density can be absolutely calibrated, giving additional diagnostic information to the radiologist.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government